ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Centessa Pharmaceuticals Plc

Centessa Pharmaceuticals Plc (0ACX)

0.00
0.00
( 0.00% )

Centessa Pharmaceuticals Plc Financial Summary

The current 0ACX market cap is 0. The company's latest EPS is USD and P/E is N/A.

Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 006.85M
Operating Income -374.08M-212.26M-171.28M
Net Income -381.07M-216.21M-151.09M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 629.64M444.31M360.25M
Total Liabilities 138.08M108.14M124M
Total Equity 491.55M336.17M236.24M

Cash Flow

Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -135.11M-200.55M-160.34M
Investing 63.26M-931k-127M
Financing 660.15M457k21.12M
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 0
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Centessa Pharmaceuticals Plc
Address 3rd floor
cheshire WA14 2DT
Website https://www.centessa.com
Industry coml physical, biologcl resh (8731)

Your Recent History

Delayed Upgrade Clock